HbA1c - the gold standard in the assessment of diabetes treatment?;HbA1c - Goldstandard in der Beurteilung der Therapie des Diabetes?

Deutsche Medizinische Wochenschrift

Volumn 131, Issue , 2006, Pages S243-S246

  Landgraf, R ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN;

BLOOD; BLOOD GLUCOSE MONITORING; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; PREDICTION AND FORECASTING; REVIEW; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 35548973496     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-2006-956282     Document Type: Article

References (18)

1. Davis TME, Cull CA, Holmann RR for the UKPDS Group. Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55). Diabetes Care 2001; 24: 1167-1174
2. Doran T, Fullwood C, Gravelle H et al. Pay-for-performance programs in family practices in the United Kingdom. New Engl J Med 2006; 355: 375-384
3. Epstein AM. Paying for performance in the United States and abroad. New Engl J Med 2006; 355: 406-408
4. Harding AH, Sargeant LA, Welch A et al. Fat consumption and HbA(1c) levels: the EPIC-Norfolk study. Diabetes Care 2001; 24: 1911-1916
5. Harding AH, Sargeant LA, Khaw KT et al. Cross-sectional association between total level and type of alcohol consumption and glycosylated haemoglobin level: the EPIC-Norfolk Study. Eur J Clin Nutr 2002; 56: 882-890
6. Innerfield RJ. Evidence for the direct inhibition of glycation by the biguanide metformin. Diabetologia 2005; 48 (Suppl 1): A416
7. Jeppsson JO, Kobold U, Barr J et al.; International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 2002; 40: 78-89
8. Jiao Y, Okumiya T, Saibara T, Park K, Sasaki M. Abnormally decreased HbA1c can be assessed with erythrocyte creatine in patients with a shortened erythrocyte age. Diabetes Care 1998; 21: 1732-1735
9. Kiho T, Kato M, Usui S, Hirano K. Effect of buformin and metformin on formation of advanced glycation end products by methylglyoxal. Clin Chim Acta 2005; 358: 139-145
10. Kilpatrick ES, Keevilt BG, Richmond KL, Newland P, Addison GM. Plasma 1,5-anhydroglucitol concentrations are influenced by variations in the renal threshold for glucose. Diabet Med 1999; 16: 496-499
11. McCarter RJ, Hempe JM, Gomez R, Chalew SA. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care 2004; 27: 1259-1264
12. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 2003; 26: 881-885
13. Roberts WL, Safar-Pour S, De BK, Rohlfing CL, Weykamp CW, Little RR. Effects of hemoglobin C and S traits on glycohemoglobin measurements by eleven methods. Clin Chem 2005; 51: 776-778
14. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care 2002; 25: 275-278
15. Schlichtkrull J, Munck O, Jersild M. The m-valve, an index of blood-sugar control in diabetics. Acta Med Scand 1965; 177: 95-102
16. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970; 19: 644-655
17. Service FJ, O'Brien PC, Rizza RA. Measurements of glucose control. Diabetes Care 1987; 10: 225-237
18. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-412